Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geron Corp (NQ: GERN )

4.670 -0.200 (-4.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Geron Corp

< Previous 1 2 3 4 5 Next >
Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.
From Geron Corporation
Via Business Wire
Geron Corporation Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Plus Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $227.8 Million
From Geron Corporation
Via Business Wire
Geron Corporation Announces Pricing of $198 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
From Geron Corporation
Via Business Wire
Geron Corporation Announces Proposed Public Offering of Common Stock
From Geron Corporation
Via Business Wire
Geron (NASDAQ: GERN) Reports Positive Results From IMerge Phase 3 Trial of Imetelstat for Lower Risk MDS
Geron Corporation (NASDAQ: GERN) is engaged as a late-stage biopharmaceutical company, which is focused on the research and development of 
Via Spotlight Growth
Geron Announces Positive Top-Line Results from IMerge Phase 3 Trial of Imetelstat in Lower Risk MDS
From Geron Corporation
Via Business Wire
Geron Announces Conference Call for Top-Line Results from IMerge Phase 3
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Reports Oral Presentation at ASH Annual Meeting Highlighting Continuous Long-Term Transfusion Independence with Imetelstat Treatment in Lower Risk MDS Patients
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron to Participate in Stifel 2022 Healthcare Conference
From Geron Corporation
Via Business Wire
Geron Announces Presentations at Upcoming ASH Annual Meeting Including Long-term Phase 2 Data Showing Continuous Durable Transfusion Independence in Patients with Lower Risk MDS
From Geron Corporation
Via Business Wire
Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones
From Geron Corporation
Via Business Wire
Geron to Announce Third Quarter 2022 Financial Results on November 3, 2022
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors
From Geron Corporation
Via Business Wire
Geron to Present at Upcoming Investor Conferences
From Geron Corporation
Via Business Wire
Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Corporation Reports Second Quarter 2022 Financial Results
From Geron Corporation
Via Business Wire
Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022
From Geron Corporation
Via Business Wire
Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Corporation Announces Expansion of Existing Loan Facility
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Corporation Announces Appointment of Faye Feller, M.D. to Chief Medical Officer and Transition of Aleksandra Rizo, M.D., Ph.D. to Senior Advisor Role
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron to Present at the H.C. Wainwright Global Investment Conference
From Geron Corporation
Via Business Wire
Geron Corporation Reports First Quarter 2022 Financial Results
From Geron Corporation
Via Business Wire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.